| Bacillus anthracis |
Bacillus anthracis |
IC50 |
nan |
None |
10.1128/aac.01029-10 |
| Bos taurus |
Adenosine deaminase |
Inhibition |
15.0 |
% |
10.1021/jm970301s |
| Bos taurus |
Adenosine deaminase |
k cat |
76.4 |
s-1 |
10.1021/jm020246+ |
| Bos taurus |
Adenosine deaminase |
k cat |
76.4 |
s-1 |
10.1021/jm040027j |
| Bos taurus |
Adenosine deaminase |
k cat/Km |
3.1 |
uM-1 s-1 |
10.1021/jm040027j |
| Bos taurus |
Adenosine deaminase |
Km |
24500.0 |
nM |
10.1021/jm020246+ |
| Bos taurus |
Adenosine deaminase |
Km |
24500.0 |
nM |
10.1021/jm040027j |
| Bos taurus |
Adenosine deaminase |
Km |
25000.0 |
nM |
10.1021/jm00347a023 |
| Bos taurus |
Adenosine deaminase |
Km |
29000.0 |
nM |
10.1021/jm00149a033 |
| Bos taurus |
Adenosine deaminase |
Km |
29000.0 |
nM |
10.1021/jm00364a023 |
| Bos taurus |
Adenosine deaminase |
Km |
30000.0 |
nM |
10.1021/jm00055a009 |
| Bos taurus |
Adenosine deaminase |
Km |
31000.0 |
nM |
10.1021/jm00389a015 |
| Bos taurus |
Adenosine deaminase |
Km |
32000.0 |
nM |
10.1016/j.bmcl.2006.04.085 |
| Bos taurus |
Adenosine deaminase |
Km |
33000.0 |
nM |
10.1021/jm00369a008 |
| Bos taurus |
Adenosine deaminase |
Km |
42000.0 |
nM |
10.1016/s0960-894x(99)00639-3 |
| Bos taurus |
Adenosine deaminase |
Km |
43240.0 |
nM |
10.1021/jm0004446 |
| Bos taurus |
Adenosine deaminase |
Km |
45300.0 |
nM |
10.1021/jm00023a004 |
| Bos taurus |
Adenosine deaminase |
Km |
50450.0 |
nM |
10.1016/S0960-894X(01)80350-4 |
| Bos taurus |
Adenosine deaminase |
Ratio |
6.9 |
None |
10.1016/s0960-894x(99)00639-3 |
| Bos taurus |
Adenosine deaminase |
Relative Vmax |
1.0 |
None |
10.1021/jm00023a004 |
| Bos taurus |
Adenosine deaminase |
Relative Vmax |
1.0 |
None |
10.1021/jm0004446 |
| Bos taurus |
Adenosine deaminase |
Relative Vmax |
100.0 |
None |
10.1016/s0960-894x(99)00639-3 |
| Bos taurus |
Adenosine deaminase |
Vmax |
0.76 |
uM min-1 unit-1 |
10.1016/S0960-894X(01)80350-4 |
| Bos taurus |
Adenosine deaminase |
Vmax |
289.0 |
uM min-1 (mg of protein)-1 |
10.1016/s0960-894x(99)00639-3 |
| Bos taurus |
Adenosine deaminase |
Vmax |
435.0 |
M min-1 mg-1 |
10.1021/jm00149a033 |
| Bos taurus |
Bos taurus |
Vmax |
435.0 |
uM min-1 mg-1 |
10.1021/jm00364a023 |
| Bos taurus |
cAMP-dependent protein kinase A |
IC50 |
160000.0 |
nM |
10.1016/0960-894X(96)00140-0 |
| Bos taurus |
cAMP-dependent protein kinase A |
IC50 |
1100000.0 |
nM |
10.1016/0960-894X(96)00140-0 |
| Bos taurus |
cAMP-dependent protein kinase A |
Ki |
15000.0 |
nM |
10.1016/0960-894X(96)00140-0 |
| Bos taurus |
cAMP-dependent protein kinase A |
Ratio |
6.9 |
None |
10.1016/0960-894X(96)00140-0 |
| Bos taurus |
Serum albumin |
Activity |
nan |
None |
10.1016/j.bmcl.2012.09.088 |
| Canis lupus familiaris |
Canis familiaris |
BP |
60.0 |
mmHg |
10.1021/jm00177a021 |
| Canis lupus familiaris |
Canis familiaris |
Duration |
2.0 |
min |
10.1021/jm00177a021 |
| Canis lupus familiaris |
Canis familiaris |
Duration |
4.0 |
min |
10.1021/jm00177a021 |
| Canis lupus familiaris |
Canis familiaris |
EC50 |
0.12 |
nM |
10.1021/jm00159a020 |
| Canis lupus familiaris |
Canis familiaris |
HR |
52.0 |
% |
10.1021/jm00177a021 |
| Canis lupus familiaris |
Canis familiaris |
PO2 |
200.0 |
% |
10.1021/jm00177a021 |
| Cavia porcellus |
Adenosine A1 receptor |
EC50 |
3388.44 |
nM |
10.1021/jm00108a014 |
| Cavia porcellus |
Adenosine A1 receptor |
EC50 |
3388.44 |
nM |
10.1021/jm00108a015 |
| Cavia porcellus |
Cavia porcellus |
EC50 |
340000.0 |
nM |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
EC50 |
460000.0 |
nM |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
EC50 |
550000.0 |
nM |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
EC50 |
570000.0 |
nM |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
1.1 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
1.4 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
1.7 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
1.8 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
96.1 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
96.8 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
98.3 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Ratio |
119.7 |
None |
10.1021/jm031143+ |
| Cavia porcellus |
Cavia porcellus |
Relative activity |
3.9 |
None |
10.1021/jm00076a023 |
| Cavia porcellus |
Cavia porcellus |
Relative activity |
nan |
None |
10.1021/jm00076a023 |
| Cavia porcellus |
Ileum |
Activity |
0.0 |
% |
10.1021/np50060a041 |
| Cavia porcellus |
Ileum |
Inhibition |
85.0 |
% |
10.1021/np50060a041 |
| Chlorocebus aethiops |
BSC-1 |
Inhibition |
86.79 |
% |
10.1021/jm00355a007 |
| Chlorocebus sabaeus |
Vero |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Chlorocebus sabaeus |
Vero |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Coxsackievirus B4 |
Coxsackievirus B4 |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Coxsackievirus B4 |
Coxsackievirus B4 |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Coxsackievirus B4 |
Coxsackievirus B4 |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
0.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
0.04 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
7.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
8.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
19.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
22.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
36.0 |
% |
10.1021/jm00012a028 |
| Cricetulus griseus |
CHO-K1-BH4 |
Inhibition |
43.0 |
% |
10.1021/jm00012a028 |
| Eimeria tenella |
Eimeria tenella |
No. of chicks |
0.0 |
None |
10.1021/jm00351a007 |
| Escherichia coli O157:H7 |
5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase |
Drug metabolism |
2100.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| Gallus gallus |
Avidin |
Activity |
nan |
None |
10.1016/j.bmcl.2012.09.088 |
| Gallus gallus |
Avidin |
Kd |
117000.0 |
nM |
10.1016/j.bmcl.2012.09.088 |
| Gallus gallus |
Avidin |
Kq |
1.28 |
10'11L/mol/s |
10.1016/j.bmcl.2012.09.088 |
| Gallus gallus |
Gallus gallus |
MIC |
20.0 |
ug.mL-1 |
10.1021/jm00351a007 |
| Homo sapiens |
A549 |
Activity |
nan |
None |
10.1021/np4005773 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
Activity |
-66.4 |
% |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
Affinity constant |
0.01 |
uM |
10.1021/jm00345a001 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
39.0 |
nM |
10.1021/jm3004834 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
69.18 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
310.0 |
nM |
10.1016/j.bmcl.2010.05.056 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
310.0 |
nM |
10.1016/j.bmcl.2011.02.053 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
310.0 |
nM |
10.1021/acs.jmedchem.5b00828 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
310.0 |
nM |
10.1021/jm4011669 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
1410.0 |
nM |
10.1021/jm3004834 |
| Homo sapiens |
Adenosine A1 receptor |
EC50 |
2511.89 |
nM |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
Emax |
51.09 |
% |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
Emax |
91.4 |
% |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
2.344 |
nM |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
Inhibition |
13.0 |
% |
10.1016/j.ejmech.2021.113607 |
| Homo sapiens |
Adenosine A1 receptor |
K |
0.048 |
/min |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
K |
1.65 |
10^5/M/min |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
Kd |
295.12 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
Kd |
nan |
nM |
10.1021/jm040842z |
| Homo sapiens |
Adenosine A1 receptor |
KD hydro |
nan |
None |
10.1021/jm040842z |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
812.83 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A1 receptor |
log(activity) |
0.9 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
pKA |
4.6 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A1 receptor |
TIME |
0.3525 |
hr |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
3900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
25.12 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
700.0 |
nM |
10.1016/j.bmcl.2010.05.056 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
700.0 |
nM |
10.1016/j.bmcl.2011.02.053 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
700.0 |
nM |
10.1021/jm4011669 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
730.0 |
nM |
10.1021/acs.jmedchem.5b00828 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
5754.4 |
nM |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2a receptor |
EC50 |
40000.0 |
nM |
10.1021/jm00077a017 |
| Homo sapiens |
Adenosine A2a receptor |
Emax |
21.53 |
% |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A2a receptor |
Emax |
65.9 |
% |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2a receptor |
Inhibition |
3.0 |
% |
10.1016/j.ejmech.2021.113607 |
| Homo sapiens |
Adenosine A2a receptor |
K |
0.016 |
/s |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A2a receptor |
K |
9.53 |
10^5/M/s |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A2a receptor |
Kd |
17.3 |
nM |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
20.0 |
nM |
10.1021/jm201461q |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
150.0 |
nM |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
700.0 |
nM |
10.1016/j.ejmech.2019.06.050 |
| Homo sapiens |
Adenosine A2a receptor |
log(activity) |
0.0 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2a receptor |
pKA |
5.6 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2b receptor |
Activity |
nan |
None |
10.1016/j.bmcl.2017.11.019 |
| Homo sapiens |
Adenosine A2b receptor |
Displacement |
10.0 |
% |
10.1021/jm9905965 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
52.48 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
23500.0 |
nM |
10.1021/acs.jmedchem.5b00828 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
24000.0 |
nM |
10.1016/j.bmcl.2010.05.056 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
24000.0 |
nM |
10.1016/j.bmcl.2011.02.053 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
24000.0 |
nM |
10.1021/acs.jmedchem.0c01431 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
24000.0 |
nM |
10.1021/jm4011669 |
| Homo sapiens |
Adenosine A2b receptor |
EC50 |
51286.14 |
nM |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2b receptor |
Emax |
59.07 |
% |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A2b receptor |
Emax |
70.4 |
% |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2b receptor |
Inhibition |
4.0 |
% |
10.1016/j.ejmech.2021.113607 |
| Homo sapiens |
Adenosine A2b receptor |
log(activity) |
0.3 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2b receptor |
pKA |
3.8 |
None |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A2 receptor |
Affinity constant |
10.0 |
uM |
10.1021/jm00345a001 |
| Homo sapiens |
Adenosine A2 receptor |
EC50 |
51.29 |
nM |
10.1021/jm00108a014 |
| Homo sapiens |
Adenosine A2 receptor |
EC50 |
51.29 |
nM |
10.1021/jm00108a015 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
1700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
Activity |
-38.7 |
% |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A3 receptor |
Activity |
10.0 |
% |
10.1021/jm050968b |
| Homo sapiens |
Adenosine A3 receptor |
Activity |
nan |
None |
10.1021/jm050968b |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
13.49 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
290.0 |
nM |
10.1016/j.bmcl.2010.05.056 |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
290.0 |
nM |
10.1016/j.bmcl.2011.02.053 |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
290.0 |
nM |
10.1021/acs.jmedchem.5b00828 |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
290.0 |
nM |
10.1021/jm4011669 |
| Homo sapiens |
Adenosine A3 receptor |
EC50 |
1040.0 |
nM |
10.1021/jm050968b |
| Homo sapiens |
Adenosine A3 receptor |
Emax |
24.71 |
% |
10.1021/acs.jmedchem.2c01414 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
1.148 |
nM |
10.1021/acs.jmedchem.5b01402 |
| Homo sapiens |
Adenosine A3 receptor |
Inhibition |
10.0 |
% |
10.1016/j.ejmech.2021.113607 |
| Homo sapiens |
Adenosine A3 receptor |
K |
0.077 |
/s |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A3 receptor |
K |
2.49 |
10^4/M/s |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A3 receptor |
Kd |
740.0 |
nM |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
290.0 |
nM |
10.1021/acsmedchemlett.2c00099 |
| Homo sapiens |
Adenosine deaminase |
Ka |
100000000.0 |
M-1 |
10.1021/jm990174v |
| Homo sapiens |
Adenosine deaminase |
Ki |
2180000.0 |
nM |
10.1021/jm00077a017 |
| Homo sapiens |
Adenosine deaminase |
Km |
5000.0 |
nM |
10.1021/jm010418n |
| Homo sapiens |
Adenosine deaminase-like protein |
Activity |
nan |
None |
10.1021/jm200650j |
| Homo sapiens |
Adenosine kinase |
Activity |
8.0 |
% |
10.1021/jm500497v |
| Homo sapiens |
Adenosine kinase |
Activity |
20.0 |
% |
10.1021/jm500497v |
| Homo sapiens |
Adenosine kinase |
Activity |
73.0 |
% |
10.1021/acs.jmedchem.8b01258 |
| Homo sapiens |
Adenosine kinase |
Activity |
100.0 |
% |
10.1021/jm500497v |
| Homo sapiens |
Adenosine kinase |
Drug metabolism |
60.0 |
% |
10.1021/acs.jmedchem.6b01766 |
| Homo sapiens |
Adenosine kinase |
ED50 |
10.0 |
uM |
10.1021/jm00074a024 |
| Homo sapiens |
Adenosine kinase |
Ratio |
1.0 |
None |
10.1021/jm00074a024 |
| Homo sapiens |
Adenosine receptor |
Affinity constant |
20.0 |
uM |
10.1021/jm00345a001 |
| Homo sapiens |
Adenosine receptor A1/Alpha-2A adrenergic receptor |
Activity |
nan |
None |
10.1038/nchembio.64 |
| Homo sapiens |
Adenosine receptors; A1 & A2 |
Ratio |
80.0 |
None |
10.1021/jm00108a014 |
| Homo sapiens |
Adenosine receptors; A1 & A2 |
Ratio |
80.0 |
None |
10.1021/jm00108a015 |
| Homo sapiens |
Adenosylhomocysteinase |
Inhibitory potency |
nan |
None |
10.1021/jm0490484 |
| Homo sapiens |
Adenosylhomocysteinase |
k cat |
91.2 |
M-1 |
10.1016/s0960-894x(03)00331-7 |
| Homo sapiens |
Adenosylhomocysteinase |
Ki |
nan |
nM |
10.1016/s0960-894x(03)00331-7 |
| Homo sapiens |
Adenosylhomocysteinase |
Km |
820.0 |
nM |
10.1016/s0960-894x(03)00331-7 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
-9.6 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Max (Mean) |
0.26 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
-20.32 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Max (Mean) |
-0.94 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
18.4 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Max (Mean) |
-1.777 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Ara-A |
ID50 |
242.0 |
uM |
10.1021/jm00364a033 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-61.99 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Max (Mean) |
-2.497 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-0.68 |
C |
None |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
-22.37 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Max (Mean) |
-2.383 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
1.03 |
C |
None |
| Homo sapiens |
CCRF-CEM |
ID50 |
10.0 |
uM |
10.1021/jm00074a024 |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
4775.5 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-41.78 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Max (Mean) |
-2.68 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
0.98 |
C |
None |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Kd |
184000.0 |
nM |
10.1039/C5MD00116A |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Detroit 98 |
ED50 |
0.08 |
uM |
10.1021/jm00351a007 |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmin |
Activity |
15.0 |
% |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
Endoplasmin |
Kd |
50000.0 |
nM |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
Endoplasmin |
Ki |
10000.0 |
nM |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
195000.0 |
nM |
10.1021/jm960380s |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
EC50 |
63000.0 |
nM |
10.1038/s41598-019-48829-3 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
IC50 |
17000.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
Ki |
12000.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Equilibrative nucleoside transporter 2 |
IC50 |
106000.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Equilibrative nucleoside transporter 2 |
Ki |
106000.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.04 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.19 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.25 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.58 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.59 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.7 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Fibroblast growth factor receptor |
Concentration |
50.0 |
uM |
10.1021/jm960380s |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.41 |
C |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-22.99 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Max (Mean) |
-1.921 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
-13.97 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Max (Mean) |
-3.497 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
35000.0 |
nM |
10.1021/jm00047a017 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
50000.0 |
nM |
10.1021/jm00047a017 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
100000.0 |
nM |
10.1021/jm00047a017 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
35000000.0 |
nM |
10.1021/jm00019a014 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
50000000.0 |
nM |
10.1021/jm00019a014 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
50000000.0 |
nM |
10.1021/jm9802620 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
100000000.0 |
nM |
10.1021/jm00019a014 |
| Homo sapiens |
Glyceraldehyde-3-phosphate dehydrogenase liver |
Ki |
2500000.0 |
nM |
10.1016/s0960-894x(98)00635-0 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
0.22 |
C |
None |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-9.889 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Max (Mean) |
27.78 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Inhib (Mean) |
-1.58 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Max (Mean) |
-2.615 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Heat shock cognate 71 kDa protein |
Kd |
110000.0 |
nM |
10.1021/acs.jmedchem.5b02001 |
| Homo sapiens |
Heat shock cognate 71 kDa protein |
Kd |
112201.85 |
nM |
10.1021/acs.jmedchem.5b02001 |
| Homo sapiens |
Heat shock protein HSP 90-alpha |
Activity |
29.0 |
% |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
Heat shock protein HSP 90-alpha |
Kd |
50000.0 |
nM |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
Heat shock protein HSP 90-alpha |
Ki |
3000.0 |
nM |
10.1021/acsmedchemlett.0c00509 |
| Homo sapiens |
HEK-293T |
Growth Rate |
-0.6 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
-0.36 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.79 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.98 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
HeLa |
IC50 |
10800.0 |
nM |
10.1021/jm00023a004 |
| Homo sapiens |
HeLa |
IC50 |
98850.0 |
nM |
10.1021/jm00023a004 |
| Homo sapiens |
HeLa |
IC50 |
nan |
ug.mL-1 |
10.1021/jm00023a004 |
| Homo sapiens |
HeLa |
ID50 |
27.7 |
uM |
10.1021/jm00392a029 |
| Homo sapiens |
HeLa |
ID50 |
46.0 |
uM |
10.1021/jm00392a029 |
| Homo sapiens |
HeLa |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Homo sapiens |
HeLa |
MIC50 |
10.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Homo sapiens |
HeLa |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Homo sapiens |
HEp-2 |
IC50 |
700.0 |
nM |
10.1021/jm00370a018 |
| Homo sapiens |
HEp-2 |
IC50 |
20000.0 |
nM |
10.1021/jm00370a018 |
| Homo sapiens |
HepG2 |
IC50 |
18460.0 |
nM |
10.1016/j.ejmech.2018.11.011 |
| Homo sapiens |
HepG2 |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
High-affinity choline transporter |
IC50 |
199.53 |
nM |
None |
| Homo sapiens |
High-affinity choline transporter |
IC50 |
570.65 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-18.7 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
2.55 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-79 specific |
IC50 |
100000.0 |
nM |
10.1021/acsmedchemlett.6b00519 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-79 specific |
Inhibition |
26.0 |
% |
10.1016/j.bmcl.2016.07.041 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
IC50 |
5940.0 |
nM |
10.1021/jm00401a018 |
| Homo sapiens |
Homo sapiens |
IC50 |
6000.0 |
nM |
10.1021/jm950906t |
| Homo sapiens |
Homo sapiens |
IC50 |
100000.0 |
nM |
10.1021/jm950906t |
| Homo sapiens |
Inosine-5'-monophosphate dehydrogenase 1 |
Ki |
100000.0 |
nM |
10.1016/j.bmc.2008.06.003 |
| Homo sapiens |
Inosine-5'-monophosphate dehydrogenase 2 |
Ki |
100000.0 |
nM |
10.1016/j.bmc.2008.06.003 |
| Homo sapiens |
Insulin receptor |
Concentration |
50.0 |
uM |
10.1021/jm960380s |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
25929.0 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
KB |
ID50 |
25.4 |
uM |
10.1021/jm00392a029 |
| Homo sapiens |
KB |
ID50 |
89.8 |
uM |
10.1021/jm00392a029 |
| Homo sapiens |
KETR3 |
Activity |
nan |
None |
10.1021/np4005773 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
-13.13 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Max (Mean) |
-2.662 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
0.35 |
C |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
MCF7 |
Activity |
0.1 |
uM |
10.1021/np9006298 |
| Homo sapiens |
MCF7 |
Activity |
100.0 |
uM |
10.1021/np9006298 |
| Homo sapiens |
MCF7 |
Activity |
nan |
None |
10.1021/np4005773 |
| Homo sapiens |
MCF7 |
Activity |
nan |
None |
10.1021/np9006298 |
| Homo sapiens |
MCF7 |
Inhibition |
90.0 |
% |
10.1021/np9006298 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 7 |
Kd |
4400.0 |
nM |
10.1016/j.bmcl.2016.12.064 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 7 |
Kd |
34000.0 |
nM |
10.1016/j.bmcl.2016.12.064 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
N6-adenosine-methyltransferase catalytic subunit |
Activity |
63.0 |
% |
10.1016/j.ejmech.2022.114118 |
| Homo sapiens |
N6-adenosine-methyltransferase catalytic subunit |
IC50 |
495000.0 |
nM |
10.1016/j.ejmech.2022.114118 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PBMC |
IC50 |
1867000.0 |
nM |
10.1016/j.bmcl.2014.05.043 |
| Homo sapiens |
PBMC |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2014.05.043 |
| Homo sapiens |
Peregrin |
Delta TM |
-1.24 |
C |
None |
| Homo sapiens |
Phosphatidylinositol 4-kinase, PI4K |
IC50 |
30300.0 |
nM |
10.1021/jm00170a005 |
| Homo sapiens |
Phosphatidylinositol 4-kinase, PI4K |
Ki |
19200.0 |
nM |
10.1021/jm00170a005 |
| Homo sapiens |
Phosphatidylinositol 4-kinase, PI4K |
Km |
178900.0 |
nM |
10.1021/jm00170a005 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphoglycerate kinase |
IC50 |
3000000.0 |
nM |
10.1021/jm000287a |
| Homo sapiens |
Platelet-derived growth factor receptor beta |
Concentration |
50.0 |
uM |
10.1021/jm960380s |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C beta |
IC50 |
278000.0 |
nM |
10.1016/s0960-894x(99)00210-3 |
| Homo sapiens |
Purine nucleoside phosphorylase |
Activity |
0.0 |
% |
10.1021/jm00207a008 |
| Homo sapiens |
Purine nucleoside phosphorylase |
Inhibition |
30.0 |
% |
10.1021/jm00207a008 |
| Homo sapiens |
Purine nucleoside phosphorylase |
Ki |
2000000.0 |
nM |
10.1021/jm00207a008 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
125892.5 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
1600000.0 |
nM |
10.1021/jm960380s |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
1500.3 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
9466.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-0.01 |
C |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serum |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.5b00575 |
| Homo sapiens |
Signal transducer and activator of transcription 6 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
S-methyl-5-thioadenosine phosphorylase |
Drug metabolism |
596.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| Homo sapiens |
Sodium/nucleoside cotransporter 1 |
Drug transport |
nan |
None |
10.1124/dmd.112.049858 |
| Homo sapiens |
Sodium/nucleoside cotransporter 1 |
IC50 |
5500.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Sodium/nucleoside cotransporter 1 |
Ki |
1800.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Sodium/nucleoside cotransporter 2 |
Drug transport |
nan |
None |
10.1124/dmd.112.049858 |
| Homo sapiens |
Sodium/nucleoside cotransporter 2 |
IC50 |
5500.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Sodium/nucleoside cotransporter 2 |
Ki |
5300.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Solute carrier family 28 member 3 |
Drug transport |
nan |
None |
10.1124/dmd.112.049858 |
| Homo sapiens |
Solute carrier family 28 member 3 |
IC50 |
3300.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Solute carrier family 28 member 3 |
Ki |
2100.0 |
nM |
10.1124/dmd.112.049858 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
180.3 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
96.48 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
-13.23 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Max (Mean) |
-2.89 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
T47D |
Activity |
2.0 |
uM |
10.1021/np9006298 |
| Homo sapiens |
T47D |
Activity |
69.0 |
uM |
10.1021/np9006298 |
| Homo sapiens |
T47D |
Activity |
100.0 |
uM |
10.1021/np9006298 |
| Homo sapiens |
T47D |
Activity |
nan |
None |
10.1021/np9006298 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.04 |
C |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
-21.88 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Max (Mean) |
-0.08 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
0.78 |
C |
None |
| Homo sapiens |
U2OS |
Growth Rate |
0.47 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.54 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.77 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
U2OS |
Growth Rate |
0.84 |
None |
10.6019/CHEMBL5058564 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
ID50 |
21.0 |
ug ml-1 |
10.1021/jm00353a011 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
ID50 |
22.0 |
uM |
10.1021/jm00364a033 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
ID50 |
42.0 |
uM |
10.1021/jm00364a033 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
Inhibition |
0.0 |
% |
10.1021/jm00355a007 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
Inhibition |
96.5 |
% |
10.1021/jm00355a007 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
MIC50 |
200.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
VR |
2.5 |
None |
10.1021/jm00364a033 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Inhibition |
nan |
% |
10.1021/np4005773 |
| Human respirovirus 1 |
Human respirovirus 1 |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human respirovirus 1 |
Human respirovirus 1 |
MIC50 |
3.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Human respirovirus 1 |
Human respirovirus 1 |
MIC50 |
200.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mammalian orthoreovirus 1 |
Mammalian orthoreovirus 1 |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mammalian orthoreovirus 1 |
Mammalian orthoreovirus 1 |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Measles morbillivirus |
Measles morbillivirus |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Measles morbillivirus |
Measles morbillivirus |
MIC50 |
3.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Measles morbillivirus |
Measles morbillivirus |
MIC50 |
200.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mus musculus |
Adenosine deaminase |
Km |
7800.0 |
nM |
10.1021/jm00376a025 |
| Mus musculus |
Equilibrative nucleoside transporter 1 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Mus musculus |
Equilibrative nucleoside transporter 2 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Mus musculus |
Heart |
Activity |
11.5 |
% |
10.1016/j.bmc.2008.12.011 |
| Mus musculus |
Heart |
Activity |
13.6 |
min |
10.1016/j.bmc.2008.12.011 |
| Mus musculus |
J774.A1 |
Activity |
nan |
None |
10.1128/aac.01029-10 |
| Mus musculus |
L1210 |
Cures |
1.0 |
None |
10.1021/jm00142a009 |
| Mus musculus |
L1210 |
EC50 |
1869000.0 |
nM |
10.1016/j.bmcl.2014.05.043 |
| Mus musculus |
L1210 |
IC50 |
991000.0 |
nM |
10.1016/j.bmcl.2014.05.043 |
| Mus musculus |
L1210 |
ID50 |
4e-07 |
M |
10.1021/jm00142a009 |
| Mus musculus |
L1210 |
ID50 |
23.6 |
uM |
10.1021/jm00392a029 |
| Mus musculus |
L1210 |
ILS |
24.0 |
None |
10.1021/jm00142a009 |
| Mus musculus |
L1210 |
ILS |
48.0 |
None |
10.1021/jm00142a009 |
| Mus musculus |
L1210 |
Inhibition |
32.79 |
% |
10.1016/j.bmcl.2014.05.043 |
| Mus musculus |
L1210 |
Inhibition |
132.32 |
% |
10.1016/j.bmcl.2014.05.043 |
| Mus musculus |
L1210 |
MIC50 |
2.7 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mus musculus |
L1210 |
MIC50 |
3.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mus musculus |
L1210 |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Mus musculus |
L1210 |
Ratio IC50/EC50 |
0.2 |
None |
10.1016/j.bmcl.2014.05.043 |
| Mus musculus |
L1210 |
Toxicity |
nan |
None |
10.1021/jm00142a009 |
| Mus musculus |
L cells |
ED50 |
0.3 |
uM |
10.1021/jm00351a007 |
| Mus musculus |
Mus musculus |
ID50 |
10.8 |
uM |
10.1021/jm00392a029 |
| Mus musculus |
Mus musculus |
ILS |
33.0 |
% |
10.1021/jm00147a043 |
| Mus musculus |
Mus musculus |
MST |
12.0 |
day |
10.1021/jm00147a043 |
| Mus musculus |
Mus musculus |
No. of mice |
1.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
No. of mice |
3.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
No. of mice |
6.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
No. of mice |
7.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
No. of mice |
10.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
Survival |
0.0 |
% |
10.1021/jm950906t |
| Mus musculus |
Mus musculus |
Survival rate |
3.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Mus musculus |
Survival rate |
4.0 |
None |
10.1021/jm00389a005 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
15848.9 |
nM |
None |
| Mus musculus |
P388 |
ID50 |
12.7 |
uM |
10.1021/jm00392a029 |
| Mus musculus |
P388 |
ILS |
54.0 |
None |
10.1021/jm00142a009 |
| Mus musculus |
P388 |
Toxicity |
nan |
None |
10.1021/jm00142a009 |
| Mus musculus |
RAW264.7 |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2017.04.072 |
| Mus musculus |
Sodium/nucleoside cotransporter 2 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Mus musculus |
Toll-like receptor 4 |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.5b00573 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Inhibition |
64.0 |
% |
10.1021/jm00345a009 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Inhibitory response |
64.0 |
% |
10.1021/jm981103j |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
MIC50 |
10.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Relative activity |
5.7 |
None |
10.1021/jm00076a023 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Relative activity |
6.0 |
None |
10.1021/jm00076a023 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Relative activity |
nan |
None |
10.1021/jm00076a023 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
EC50 |
112219.0 |
nM |
None |
| Plasmodium falciparum |
Spermidine synthase |
Activity |
nan |
None |
10.1021/jm7016144 |
| Poliovirus 1 |
Poliovirus 1 |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Poliovirus 1 |
Poliovirus 1 |
MIC50 |
8.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Poliovirus 1 |
Poliovirus 1 |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Rattus norvegicus |
Adenosine A1 receptor |
K |
0.079 |
/min |
10.1021/acs.jmedchem.2c01414 |
| Rattus norvegicus |
Adenosine A1 receptor |
K |
0.52 |
10^5/M/min |
10.1021/acs.jmedchem.2c01414 |
| Rattus norvegicus |
Adenosine A1 receptor |
Kd |
1949.84 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
5.1 |
nM |
10.1021/jm00174a004 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
10.0 |
nM |
10.1021/jm00170a031 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
10.0 |
nM |
10.1021/jm9905965 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
12.8 |
nM |
10.1016/S0960-894X(01)81110-0 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
12.8 |
nM |
10.1021/jm00128a002 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
870.96 |
nM |
10.1021/acs.jmedchem.2c01414 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
29000.0 |
nM |
10.1021/jm00007a014 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
nan |
nM |
10.1021/jm00116a007 |
| Rattus norvegicus |
Adenosine A1 receptor |
TIME |
0.2143 |
hr |
10.1021/acs.jmedchem.2c01414 |
| Rattus norvegicus |
Adenosine A2a receptor |
Displacement |
25.0 |
% |
10.1021/jm00007a014 |
| Rattus norvegicus |
Adenosine A2a receptor |
Ki |
30.0 |
nM |
10.1021/jm9905965 |
| Rattus norvegicus |
Adenosine A2a receptor |
Ki |
nan |
nM |
10.1021/jm00116a007 |
| Rattus norvegicus |
Adenosine A2 receptor |
Ki |
5.0 |
nM |
10.1021/jm00170a031 |
| Rattus norvegicus |
Adenosine A2 receptor |
Ki |
37.0 |
nM |
10.1016/S0960-894X(01)81110-0 |
| Rattus norvegicus |
Adenosine A2 receptor |
Ki |
37.0 |
nM |
10.1021/jm00128a002 |
| Rattus norvegicus |
Adenosine A3 receptor |
Displacement |
10.0 |
% |
10.1021/jm00007a014 |
| Rattus norvegicus |
Adenosine A3 receptor |
Ki |
100.0 |
nM |
10.1021/jm9905965 |
| Rattus norvegicus |
Adenosine receptors; A1 & A2 |
Ratio |
2.9 |
None |
10.1016/S0960-894X(01)81110-0 |
| Rattus norvegicus |
Adenosine receptors; A1 & A2 |
Ratio |
2.9 |
None |
10.1021/jm00128a002 |
| Rattus norvegicus |
Adenosine receptors; A1 & A3 |
Ratio |
100.0 |
None |
10.1021/jm9905965 |
| Rattus norvegicus |
Adenylate cyclase type V |
IC50 |
300000.0 |
nM |
10.1021/jm0303599 |
| Rattus norvegicus |
Adenylate kinase 1 |
Ki |
580000.0 |
nM |
10.1021/jm00352a016 |
| Rattus norvegicus |
Adenylate kinase 1 |
Ki |
19000000.0 |
nM |
10.1021/jm00352a016 |
| Rattus norvegicus |
Adenylate kinase 1 |
Ki |
82000000.0 |
nM |
10.1021/jm00352a016 |
| Rattus norvegicus |
Adenylate kinase 2 |
Ki |
87000000.0 |
nM |
10.1021/jm00352a016 |
| Rattus norvegicus |
Adenylate kinase 2 |
Ki |
92000000.0 |
nM |
10.1021/jm00352a016 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Equilibrative nucleoside transporter 1 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Rattus norvegicus |
Equilibrative nucleoside transporter 2 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
PC-12 |
Activity |
80.0 |
% |
10.1021/np0605182 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
1613.7 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
26000.0 |
nM |
10.1021/jm00100a020 |
| Rattus norvegicus |
Rattus norvegicus |
Radioactivity |
1.0 |
% |
10.1021/jm011070z |
| Rattus norvegicus |
Sodium/nucleoside cotransporter 1 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Rattus norvegicus |
Sodium/nucleoside cotransporter 2 |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| Semliki Forest virus |
Semliki Forest virus |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Semliki Forest virus |
Semliki Forest virus |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.7 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
31.99 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-5.46 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.02 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.21 |
% |
10.6019/CHEMBL4495565 |
| Sindbis virus |
Sindbis virus |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Sindbis virus |
Sindbis virus |
MIC50 |
3.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Sindbis virus |
Sindbis virus |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Streptomyces avidinii |
Streptavidin |
Activity |
nan |
None |
10.1016/j.bmcl.2012.09.088 |
| Streptomyces avidinii |
Streptavidin |
Kd |
168000.0 |
nM |
10.1016/j.bmcl.2012.09.088 |
| Streptomyces avidinii |
Streptavidin |
Kq |
8.5 |
10'10L/mol/s |
10.1016/j.bmcl.2012.09.088 |
| Sulfolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 /P2) |
Purine nucleoside phosphorylase |
Drug metabolism |
57000.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099) |
5-methylthioadenosine/S-adenosylhomocysteine deaminase |
Kcat |
2.3 |
/s |
10.1038/nature05981 |
| Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099) |
5-methylthioadenosine/S-adenosylhomocysteine deaminase |
Kcat/Km |
9.2 |
10^3/M/s |
10.1038/nature05981 |
| Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099) |
5-methylthioadenosine/S-adenosylhomocysteine deaminase |
Km |
250000.0 |
nM |
10.1038/nature05981 |
| Toxoplasma gondii |
Adenosine kinase |
Ki |
8900.0 |
nM |
10.1021/jm800201s |
| Toxoplasma gondii |
Adenosine kinase |
Km |
2400.0 |
nM |
10.1021/jm030537y |
| Trichomonas vaginalis |
Trichomonas vaginalis |
GI |
49.7 |
% |
10.1016/j.bmcl.2012.03.087 |
| Trypanosoma brucei |
Adenosine transporter 1 |
Km |
700.0 |
nM |
10.1016/s0960-894x(00)00233-x |
| Vaccinia virus |
Vaccinia virus |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Vaccinia virus |
Vaccinia virus |
MIC50 |
400.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC50 |
2.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC50 |
3.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC50 |
4.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC50 |
300.0 |
ug.mL-1 |
10.1021/jm00148a002 |
| Zea mays |
CaM kinase I alpha |
IC50 |
116000.0 |
nM |
10.1016/s0960-894x(99)00210-3 |
| None |
ADMET |
CL |
3.0 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Drug metabolism |
2100.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| None |
ADMET |
Drug metabolism |
398000.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| None |
ADMET |
Drug metabolism |
501000.0 |
nmol/mg/hr |
10.1016/j.ejmech.2015.12.029 |
| None |
ADMET |
Km |
29000.0 |
nM |
10.1021/jm00160a046 |
| None |
ADMET |
Stability |
nan |
% |
10.1021/jm00214a040 |
| None |
ADMET |
T1/2 |
0.006944 |
hr |
10.1021/jm010418n |
| None |
ADMET |
T1/2 |
0.008333 |
hr |
10.1021/jm020246+ |
| None |
ADMET |
T1/2 |
0.008333 |
hr |
10.1021/jm040027j |
| None |
ADMET |
Virus yield |
1.6 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
3.0 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
4.3 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
4.7 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
5.0 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
5.2 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
5.5 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
5.7 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
6.7 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Virus yield |
6.8 |
log pfu ml-1 |
10.1021/jm00389a005 |
| None |
ADMET |
Vmax |
31400.0 |
c.p.m. |
10.1021/jm00170a005 |
| None |
Erythroleukemia cell line |
Differentiation |
2.0 |
% |
10.1021/jm00148a018 |
| None |
Erythroleukemia cell line |
Differentiation |
3.0 |
% |
10.1021/jm00148a018 |
| None |
Erythroleukemia cell line |
ID50 |
0.05 |
mM |
10.1021/jm00148a018 |
| None |
Erythroleukemia cell line |
ID50 |
4.0 |
mM |
10.1021/jm00148a018 |
| None |
Erythroleukemia cell line |
Optimal concentration |
0.04 |
mM |
10.1021/jm00148a018 |
| None |
Erythroleukemia cell line |
Optimal concentration |
4.0 |
mM |
10.1021/jm00148a018 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/np4005773 |
| None |
NON-PROTEIN TARGET |
Anticonvulsant activity |
nan |
None |
10.1016/s0960-894x(03)00535-3 |
| None |
NON-PROTEIN TARGET |
ID50 |
2.4 |
uM |
10.1021/jm00364a033 |
| None |
NON-PROTEIN TARGET |
Inhibition |
30.0 |
% |
10.1021/np4005773 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1021/jm00204a004 |
| None |
NON-PROTEIN TARGET |
MTD |
125.0 |
uM |
10.1021/acs.jmedchem.6b01517 |
| None |
No relevant target |
Drug metabolism |
0.82 |
10^-3L/mol/min |
10.1021/acs.jmedchem.1c00790 |
| None |
No relevant target |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.5b00575 |
| None |
No relevant target |
LogP |
0.47 |
None |
10.1021/jm00023a004 |
| None |
No relevant target |
pKa |
3.6 |
None |
10.1021/jm00149a016 |
| None |
No relevant target |
Solubility |
400.0 |
ug.mL-1 |
10.1021/jm00023a004 |
| None |
Osteoblast |
Activity |
nan |
None |
10.1128/aac.00729-05 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
Ac50 |
4.467 |
uM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
4466.8 |
nM |
None |
| None |
Unchecked |
Activity |
44.0 |
% |
10.1021/jm500497v |
| None |
Unchecked |
Activity |
58.0 |
% |
10.1021/jm500497v |
| None |
Unchecked |
Activity |
100.0 |
% |
10.1021/jm500497v |
| None |
Unchecked |
Activity |
398000.0 |
nmol/hr |
10.1016/j.ejmech.2011.10.039 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.5b01223 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm00192a009 |
| None |
Unchecked |
Activity |
nan |
None |
10.1128/aac.00010-10 |
| None |
Unchecked |
EC50 |
759.0 |
nM |
None |
| None |
Unchecked |
IC50 |
150.0 |
nM |
10.1021/jm00116a007 |
| None |
Unchecked |
IC50 |
1800.0 |
nM |
10.1021/jm00117a030 |
| None |
Unchecked |
IC50 |
2500.0 |
nM |
10.1021/jm00117a030 |
| None |
Unchecked |
IC50 |
126000.0 |
nM |
10.1016/s0960-894x(99)00210-3 |
| None |
Unchecked |
IC50 |
141000.0 |
nM |
10.1016/s0960-894x(99)00210-3 |
| None |
Unchecked |
IC50 |
300000.0 |
nM |
10.1016/s0960-894x(99)00210-3 |
| None |
Unchecked |
IC50 |
400000.0 |
nM |
10.1021/jm801627a |
| None |
Unchecked |
IC50 |
407000.0 |
nM |
10.1021/acs.jmedchem.7b01066 |
| None |
Unchecked |
IC50 |
560000.0 |
nM |
10.1021/jm801627a |
| None |
Unchecked |
IC50 |
10000000.0 |
nM |
10.1016/S0960-894X(00)80378-9 |
| None |
Unchecked |
IC50 |
11000000.0 |
nM |
10.1016/j.bmcl.2009.11.017 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmcl.2017.12.014 |
| None |
Unchecked |
Inhibition |
10.3 |
% |
10.1016/j.bmcl.2017.12.014 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
K 0.5 |
nan |
None |
10.1021/jm00076a023 |
| None |
Unchecked |
k cat/Km |
3.1 |
uM-1 s-1 |
10.1021/jm020246+ |
| None |
Unchecked |
Kd |
35000.0 |
nM |
10.1021/jm960380s |
| None |
Unchecked |
Kd |
3000000.0 |
nM |
10.1021/jm900728u |
| None |
Unchecked |
Ki |
930.0 |
nM |
10.1016/j.bmc.2007.10.054 |
| None |
Unchecked |
Ki |
300000.0 |
nM |
10.1021/acs.jmedchem.9b00182 |
| None |
Unchecked |
Km |
120.0 |
nM |
10.1016/j.ejmech.2019.112018 |
| None |
Unchecked |
Km |
160.0 |
nM |
10.1016/j.ejmech.2018.12.050 |
| None |
Unchecked |
Km |
530.0 |
nM |
10.1016/j.ejmech.2018.12.050 |
| None |
Unchecked |
Km |
530.0 |
nM |
10.1016/j.ejmech.2019.112018 |
| None |
Unchecked |
Km |
5500.0 |
nM |
10.1016/j.bmc.2007.10.054 |
| None |
Unchecked |
Potency |
1122.0 |
nM |
None |
| None |
Unchecked |
Potency |
18356.4 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Radioactivity |
14.3 |
% |
10.1021/jm011070z |
| None |
Unchecked |
Radioactivity |
15.1 |
% |
10.1021/jm011070z |
| None |
Unchecked |
Radioactivity |
19.4 |
% |
10.1021/jm011070z |
| None |
Unchecked |
Radioactivity |
22.4 |
% |
10.1021/jm011070z |
| None |
Unchecked |
Ratio |
3.1 |
None |
10.1021/jm00364a033 |
| None |
Unchecked |
Ratio |
15.0 |
None |
10.1021/jm00149a033 |
| None |
Unchecked |
Vmax |
3.13 |
microM/min |
10.1016/j.bmc.2007.10.054 |
| None |
Unchecked |
Vmax |
220.0 |
umol/min/mg |
10.1021/jm00194a028 |